Manufacturer record
Super Pharma Products: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Super Pharma Products (Madhya Pradesh) was declared Not of Standard Quality in July 2021. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 475, Ampicillin 500 mg (Ampicillin Capsules I.P.) (exp Jan 2022). CDTL Mumbai (CDSCO lab) found it not of standard quality: Assay. Listed in the July 2021 alert.
Records by type
1 record linked to Super Pharma Products in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ampicillin 500 mg (Ampicillin Capsules I.P.) | Batch 475Mfg Feb 2020 · Exp Jan 2022 | AssayAssay | CDTL MumbaiCDSCO lab | Jul 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.